Pharmaceutical preparations, namely, for the activation of PKR (pyruvate kinase R), for the activation of PKM2 (pyruvate kinase isozyme M2), and for the prevention and treatment of blood disorders, pyruvate kinase deficiency (PKD), genetically defined diseases affecting red blood cells, hemolytic anemia